KINDLER JEFFREY B 4
4 · PRECIGEN, INC. · Filed Mar 16, 2026
Research Summary
AI-generated summary of this filing
Precigen (PGEN) Director Jeffrey Kindler Receives 71,839 Shares
What Happened
- Jeffrey B. Kindler, a director of Precigen, had 71,839 restricted stock units (RSUs) vest and convert into 71,839 shares on March 13, 2026 (transaction code M — exercise/conversion of derivative). The filing shows an acquisition of 71,839 shares and a simultaneous disposition of 71,839 shares at $0 (derivative), indicating the delivered shares were not sold for cash.
- No cash proceeds are reported for the disposition (price shown as $0); the acquisition price is listed as N/A. The filing does not disclose a cash value or the number of shares retained by Kindler after the transactions in the summary provided.
Key Details
- Transaction date: March 13, 2026 (reported on Form 4 filed March 16, 2026) — filing appears timely (within the required reporting window).
- Transactions: 71,839 shares acquired via conversion of RSUs (M); 71,839 shares disposed at $0 (derivative).
- Footnotes: F1 — each RSU equals a contingent right to one Precigen common share; F2 — the RSUs vested in full on March 13, 2026.
- Shares owned after transaction: Not specified in the provided filing summary.
- Likely tax treatment: The simultaneous disposition at $0 commonly reflects company withholding or surrender of shares to cover tax withholding or related obligations (the filing does not explicitly state the reason).
Context
- These transactions reflect RSU vesting and conversion rather than an open-market buy or sale. When RSUs vest, insiders receive shares; companies often withhold or accept surrendered shares to satisfy tax withholding, which is routine and does not necessarily indicate a market view.
- Transaction code M denotes exercise or conversion of a derivative (here, RSUs converting into common stock). This is informational for investors but is typically neutral compared with outright purchases or sales.
Insider Transaction Report
Form 4
PRECIGEN, INC.PGEN
KINDLER JEFFREY B
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-13+71,839→ 202,100 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-03-13−71,839→ 0 total→ Common Stock (71,839 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
- [F2]The RSUs vested in full on March 13, 2026.
Signature
/s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact|2026-03-16